PATRICK PETITPRETZ
PATRICK PETITPRETZ publishes mostly in Pulmonary and Respiratory Medicine, Epidemiology and Surgery, on topics such as Pneumonia and Respiratory Infections, Venous Thromboembolism Diagnosis and Management and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #2,018,591 of 7,710,434 ranked researchers
- Rank in France
- #87,902 of 324,115
- Works
- 71
- Citations
- 2.1k
- Citations per work
- 30.0
What does PATRICK PETITPRETZ research?
PATRICK PETITPRETZ's work is mostly in Medicine (66%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4765.6%
- Medicine4765.6%
- Everything else2434.4%
- 1Pulmonary and Respiratory Medicine24% of their works
- 2Epidemiology20% of their works
- 3Surgery6% of their works
- 4Internal Medicine6% of their works
- 5Cardiology and Cardiovascular Medicine5% of their works
- 6Pharmacology5% of their works
Research topics
- Pneumonia and Respiratory Infections
- Venous Thromboembolism Diagnosis and Management
- Antibiotics Pharmacokinetics and Efficacy
- Acute Ischemic Stroke Management
- Pneumocystis jirovecii pneumonia detection and treatment
- Pulmonary Hypertension Research and Treatments
- Heme Oxygenase-1 and Carbon Monoxide
- Emergency and Acute Care Studies
Which keywords describe PATRICK PETITPRETZ's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Antimicrobial Resistance, Epidemiology, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Diagnosis, Risk Factors and Antithrombotic Therapy.
- Heme Oxygenase-1
- Carbon Monoxide
- Right Heart Assessment
- Pneumonia
- Ischemic Stroke
- Antibiotic Pharmacokinetics
- Clinical Outcomes
- Antithrombotic Therapy
- Diagnosis
- Community-Acquired Pneumonia
- Antimicrobial Resistance
- Clinical Practice Guidelines
- Epidemiology
- Pneumococcal Conjugate Vaccine
- Risk Factors
- Venous Thromboembolism
- Neuroprotection
- Critically Ill Patients
- Pneumocystis
- Pulmonary Hypertension
- Thrombolysis
- Emergency Department Crowding
- Patient Satisfaction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Clinical Practice Guidelines272 topics
- Antimicrobial Resistance232 topics
- Epidemiology212 topics
- Community-Acquired Pneumonia171 topic
- Pneumococcal Conjugate Vaccine171 topic
- Diagnosis142 topics
- Risk Factors142 topics
- Antithrombotic Therapy101 topic
- Venous Thromboembolism101 topic
- Clinical Outcomes72 topics
- Neuroprotection72 topics
- Antibiotic Pharmacokinetics61 topic
- Critically Ill Patients61 topic
- Ischemic Stroke41 topic
- Pneumocystis41 topic
- Pneumonia41 topic
- Pulmonary Hypertension41 topic
- Right Heart Assessment41 topic
- Thrombolysis41 topic
- Carbon Monoxide31 topic
- Emergency Department Crowding31 topic
- Heme Oxygenase-131 topic
- Patient Satisfaction31 topic
Where does PATRICK PETITPRETZ work?
PATRICK PETITPRETZ's main affiliation in the publication record is Hôpital André Mignot, France.
How many publications and citations does PATRICK PETITPRETZ have?
OpenAlex counts 71 works and 2,133 citations for PATRICK PETITPRETZ, an h-index of 21, ranking #2,018,591 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about PATRICK PETITPRETZ. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.